Nevi And Melanomas

Download PDF

Recent Publications on Nevi And Melanomas:
Pten deficiency in melanocytes results in resistance to hair graying and susceptibility to carcinogen-induced melanomagenesis. Phosphate and tensin homologue deleted on chromosome 10 (PTEN) is a tumor...	7th August, 2008	Department of Dermatology, Akita University School of Medicine, Akita,	Cancer Res. 2008 Jul 15;68(14):5760-8. DOI Direct Link
Size overlap between benign melanocytic choroidal nevi and choroidal malignant melanomas. PURPOSE: To estimate size overlap between large choroidal nevi and small...	1st August, 2008	Department of Ophthalmology, University of Cincinnati College of Medicine,	Invest Ophthalmol Vis Sci. 2008 Jul;49(7):2823-8. Epub 2008 Apr 11. DOI Direct Link
Expression of gamma-H2AX in melanocytic lesions. gamma-H2AX is a marker of activated DNA damage and is overexpressed in...	29th July, 2008	Department of Pathology, University of Michigan Medical Center, Ann Arbor,	Hum Pathol. 2008 Jul 23. DOI Direct Link
Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions. HMB45 is a mouse monoclonal antibody raised against Pmel17/gp100, a...	17th June, 2008	1Department of Pathology, Yale University School of Medicine, New Haven,	Mod Pathol. 2008 Jun 13. DOI Direct Link
G1 cell cycle regulators in congenital melanocytic nevi. Comparison with acquired nevi and melanomas. Background: Congenital nevi are one of the known risk factors for the...	23rd May, 2008	Dermatology Department, Andreas Sygros University Hospital, Athens,	J Cutan Pathol. 2008 May 20. DOI Direct Link
→View more research publications.

Nevi And Melanomas Clinical Trials:
In Vivo Confocal Scanning Laser Microscopy of Benign Nevi	Nevus Intervention: 2 Recruiting Family Study of Melanoma in Italy

Nevi And Melanomas Patents:
US Patent No.	Title
7396827	Pharmaceutical compositions and treatment methods
6653618	Contact detecting method and apparatus for an optical radiation handpiece
6631204	Similarity measurement method for the classification of medical images into predetermined categories
6613534	MAP-2 as a determinant of metastatic potential
6605080	Method and apparatus for the selective targeting of lipid-rich tissues
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Nevi And Melanomas scientists - we have details of around 8 individuals working on Nevi And Melanomas .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.